HFF
CADL icon

Halter Ferguson Financial’s Candel Therapeutics CADL Stock Holding History

Halter Ferguson Financial’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43M Buy
904,051
+155,996
+21% +$849K 0.97% 13
2025
Q4 		$4.23M Buy
748,055
+50,051
+7% +$269K 0.93% 14
2025
Q3 		$3.56M Sell
698,004
-78,512
-10% -$454K 0.81% 12
2025
Q2 		$3.93M Buy
776,516
+83,363
+12% +$429K 1.37% 10
2025
Q1 		$3.92M Buy
693,153
+11,819
+2% +$96.6K 2% 7
2024
Q4 		$5.91M Buy
681,334
+376,795
+124% +$2.23M 2.42% 7
2024
Q3 		$2.11M Buy
+304,539
New +$1.89M 1.12% 14

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Halter Ferguson Financial's CADL Position: Q1 2026 in Review

Halter Ferguson Financial increased its Candel Therapeutics (CADL) stake by 21% in Q1 2026, buying an estimated $849K and bringing the position to 904,051 shares worth $4.43M. The position accounts for 0.97% of the portfolio, ranked #13.

Halter Ferguson Financial first reported a position in CADL in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.91M in Q4 2024. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Halter Ferguson Financial held 904,051 shares of Candel Therapeutics worth $4.43M as of Q1 2026.
  • Halter Ferguson Financial bought 155,996 Candel Therapeutics shares in Q1 2026, an estimated $849K.
  • Candel Therapeutics made up 0.97% of Halter Ferguson Financial's portfolio in Q1 2026, its #13 holding.
  • Halter Ferguson Financial first reported a position in Candel Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Halter Ferguson Financial's Candel Therapeutics position peaked at $5.91M in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Halter Ferguson Financial's 13F filing for Q1 2026, filed 28 Apr 2026.